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Abstract
Objective: Blend electrospinning has been acknowledged as a cost-effective technique for the production of 
fibrous scaffolds, suitable for various biomedical applications. Coaxial electrospinning is a method variant that results 
in core-shell structures with advantages, such as delayed diffusion and protection of sensitive biomolecules. The aim of 
this work was to evaluate how different process and solution parameters affect the structural, mechanical and physical 
properties of the fibers, created by polycaprolactone (PCL). In addition, acetylsalicylic acid (ASA) that was used as a 
model anti-inflammatory and anti-thrombotic agent, was loaded within the fiber meshes in order to compare release 
kinetics between fibers produced by conventional blend and coaxial electrospinning.
Methods: Scanning electron microscopy (SEM) was used to investigate the structural and morphological 
characteristics of the fibers. The fibers’ hydrophilicity was investigated using contact angle measurements while 
the electrical conductivity of the polymeric solutions and the thermal properties of the fibers were also evaluated. 
Differential scanning calorimetry (DSC) was used to determine the fibers’ melting point and mechanical tensile tests 
were performed in order to study the mechanical properties of the fibers. Moreover, UV-vis spectroscopy was used to 
determine the release kinetics of ASA.
Results: The results indicated that increasing the concentration of PCL led to thicker and less aligned fibers. 
Furthermore, the physicochemical characterization did not reveal significant changes during the process. Coaxially 
electrospun fibers that were loaded with ASA exhibited a slower and sustained, biphasic release profile compared to 
blend electrospun fibers with 34% of ASA released during the first 8h and 97% in total after 3 months.
Conclusion: Taken together, fibrous meshes created by coaxial electrospinning using PCL, can be tailor-made by 
a careful optimization of all the process and solution parameters, in order to fit the scope of specific applications in the 
fields of biomedical engineering and drug delivery.
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Introduction
During the past two decades electrospinning has received increased 
attention as a technology for applications in the biomedical field. It is 
an electrohydrodynamic technique that can be used to generate fibers 
or particles through an one-step process [1,2]. It utilizes electrical 
forces in order to create ultra-fine polymeric fibers from polymer 
melts, blends or emulsions [3]. In addition, it is a simple, cost-effective 
and versatile method that can be used to generate non-woven fiber 
meshes of different shapes and sizes [4]. Various solution parameters 
(concentration of polymers, choice of solvents, solution viscosity and 
surface tension) and process parameters (spinning distance, applied 
voltage and solution flow rate) affect the structural, physicochemical 
and mechanical properties of the fibers [5,6].
A typical design of an electrospinning apparatus has been described 
by Chronakis et al [7]. Two of the most important process parameters 
are the solution flow rate and the applied voltage. These parameters 
together with the spinning distance have to be carefully optimized 
in order to establish a stable and reproducible process. On the other 
hand, solution properties, such as viscosity and surface tension, which 
can be adjusted by the concentration of polymers and the choice of an 
appropriate solvent, determine the “electrospinnability” of a solution 
and the fundamental properties of the fibers that are generated. In 
contrast to blend electrospinning, coaxial electrospinning involves 
two concentrically arranged nozzles that are connected to the power 
source. This can be used to create fibers with a core-shell morphology 
that can have various applications in the fields of drug delivery, tissue 
engineering and wound healing [8-11]. Here, the application of two 
different solutions with different polymers and solvents can be used to 
create products with tailor-made properties if the process is properly 
controlled [12-14]. Polycaprolactone (PCL) is a hydrophobic, semi-
crystalline polymer, approved from the Food and Drug Administration 
(FDA) in the United States of America, whose crystallinity depends on 
its molecular weight. It is easily soluble in most organic solvents, has a 
low melting point (59-64oC) and very good blend compatibility [15]. 
It presents numerous advantages, such as mechanical stability, slow 
degradation time (up to 3-4 years) and ability for long term controlled 
delivery of biomolecules of interest, such as drugs and proteins [16]. 
Additionally, the pore size of PCL scaffolds can be adjusted, in order 
to achieve proper cell seeding and tissue growth. Furthermore, the 
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was 1.35 mm. The distance between the tip of the coaxial nozzle and 
the surface of the collector was kept constant at 25 cm for all samples. 
A collector that constantly rotated at 1000 rpm (150 mm diameter and 
50 mm width), covered with an aluminum foil was used to collect the 
samples. A constant high voltage (25 kV) was used via a power source 
(Matsusada, Precision Inc., Japan) for the samples with different flow 
rate and PCL concentration. On the other hand, applied voltage of 17, 
19, 21, 23 and 25 kV for the samples with different voltage, was applied 
at the nozzle to charge the solution. The initial droplet, formed at the 
tip of the nozzle due to the solution been pumped, was elongated when 
the charge-charge repulsions created from the applied voltage overcame 
the solution’s surface tension. This subsequently led to the formation 
of a jet that was accelerated towards the collector while the solvent got 
evaporated before the jet reached the surface, thus, creating fibers that 
were deposited on the aluminum foil. Electrospinning was performed 
under constant conditions of temperature and relative humidity (T=23 
± 1oC, Rel. Humidity = 40 ± 3 %). The samples were then collected and 
left to dry overnight under vacuum. For the production of electrospun 
fibers with ASA, a core solution of 15 mg/ml ASA and 150 mg/ml 
PCL as a blend in TFE and a shell solution of 150 mg/ml PCL in TFE 
were used. The solutions were left for 24h at room temperature under 
stirring (300 rpm) to achieve homogenous mixtures. A similar set of 
process parameters was used to create the fiber mats (applied voltage = 
25 kV, nozzle to collector distance = 25 cm, core solution flow rate = 1 
ml/h, shell solution flow rate = 3 ml/h, rotating collector’s speed = 1000 
rpm). PCL fibers with encapsulated ASA using conventional blend 
electrospinning were also electrospun to serve as a control.
Characterization of electrospun fiber mats
Electrical conductivity: The electrical conductivity of the polymeric 
solutions was measured using a conductometer (SevenMulti, Mettler 
Toledo AG). Five milliliter of each different polymer solution was 
measured at 25oC. All measurements were performed in quintuplicates. 
Scanning electron microscopy (SEM): Square samples of 5×5 
mm2 were cut from each different sample and were sputter coated with 
Au/Pd for 60s before been placed inside the SEM instrument (S3400N. 
Hitachi, Japan). A high voltage of 15 kV and a tip to sample distance of 
7 mm were used to examine the samples. Magnifications of 500ˣ, 1000ˣ, 
and 4000ˣ were used both for quantitative and qualitative analysis. For 
the fiber diameter, alignment and pore size measurements pictures were 
analyzed with ImageJ software (National Institutes of Health, USA). 
Measurements were taken at 50 different fibers from each sample.
Water contact angle assay: Square strips of 10ˣ10 mm2 were cut 
from each different sample and static contact angles of fiber mats were 
measured using an optical contact angle apparatus (FM40 Easydrop, 
Krüss, Germany) at room temperature. Measurements were taken at 
0s after the droplet of bi-distilled water (1 μL) touched the surface of 
the samples. Photos at 0s were taken for the samples with different PCL 
concentrations. The contact angle data was calculated by the software 
that accompanied the apparatus. The experiments were performed in 
quintuplicates.
Mechanical testing: Rectangular samples of 15 mm gauge length 
and 10 mm width were carefully cut from each different sample. The 
thickness of each specimen was measured with a thickness gauge (Quick 
mini, Mituotoyo). Duct tape was carefully placed at each edge of the 
samples to improve the mounting on the pneumatic grips of the testing 
device. Uniaxial tensile tests were conducted on an INSTRON 5967 
Dual Column tensile testing machine with a 100 N load cell (Instron, 
USA). Ultimate tensile strength (UTS), strain at the maximum force, 
safety of PCL fibers in terms of cytotoxicity and biocompatibility 
has been demonstrated previously by several groups [4,17,18]. The 
fibrous scaffolds can be either produced under sterile conditions or be 
sterilized after their production using different methods. The combined 
properties hold great promise for potential applications in the field of 
drug delivery and tissue engineering [9,19–23].
The main focus of this study was to elucidate the effect of two 
process parameters (flow rate, applied voltage) and one solution 
parameter (PCL concentration), on the structural, mechanical 
and physical properties of PCL fibers generated via the coaxial 
electrospinning method, and to correlate the obtained data with 
previous research work in order to establish an optimized coaxial setup 
for the encapsulation of pharmaceutical agents for sustained delivery. 
In addition, acetylsalicylic acid (ASA) that was used as a model anti-
inflammatory and anti-platelet drug, was encapsulated in the fiber 
meshes in order to compare the cumulative release between fibers 
created from coaxial and conventional blend electrospinning. ASA has 
been previously investigated as a thrombosis prevention factor in PCL 
tubular grafts [22]. The same polymer (PCL) and solvent were selected 
for both core and shell solutions in order to investigate the influence 
of the electrospinning method on drug release. The final aim of this 
work is to use the coaxial electrospinning technique as a means to 
confine the encapsulated drug close to the core of the fibers and reduce 
the initial burst effect, which is normally detected in drug delivery 
carriers fabricated by blend electrospinning, even though a core-shell 
structure was not given high priority. The findings of this study can 
be used to promote drug delivery systems (DDSs) for the sustained 
release of pharmaceutical agents in clinical applications related with 
cardiovascular diseases.
Materials and Methods
Materials
Polycaprolactone (PCL) (Mn = 70000-90000) and acetylsalicylic 
acid (ASA) (≥99.0%, crystalline) were purchased from Sigma-Aldrich. 
2,2,2-trifluroethanol (TFE) was purchased from abcr GmbH & Co.KG. 
A phosphate buffer solution (PBS, pH = 7.4) was created in the lab 
using bi-distilled water. Ethanol (ROTIPURAN®, ≥99.8 % p.a., density 
= 0.79 g/cm3), used for the porosity measurements, was purchased by 
Carl Roth GmbH + Co. KG. All materials and reagents were used as 
received without further purification.
Polymer solution preparation and electrospinning
PCL was dissolved in TFE at a concentration of 150 mg/ml, for 
the samples of different flow rate and applied voltage, and at 120, 140, 
160, 180 and 200 mg/ml for the samples of different concentration. All 
polymer solutions were left for 24h at room temperature under stirring 
(300 rpm) to achieve homogenous mixtures. The polymer solutions were 
then transferred to 10 ml syringes (Omnifix; B. Braun, Germany) while 
a portion of each was held for the electrical conductivity experiments. 
These syringes were used as the polymer reservoirs both for core and 
shell solutions. With the assistance of two software-controlled pumps 
(New Era Pump Systems Inc., USA) the polymer solutions were pumped 
out of their reservoirs at a constant rate of 4 ml/h for the samples of 
different applied voltage and PCL concentration and at rates of 1, 3 and 
5 ml/h respectively for the different flow rate samples. Core and shell 
solution flow rates were the same, leading to a flow rate ratio of 1/1 
for all samples. For the core solutions disposable blunt-tipped needles 
(Nordson EFD, USA) of an inner diameter of 0.8 mm were used while 
the inner diameter of the coaxial spinneret nozzle for the shell solution 
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Young’s modulus (linear slope of the stress/strain curve) and Toughness 
were measured and analyzed (Blue-Hill software, Instron, USA). All 
experiments were done at room temperature. A strain rate of 20 mm/
min was used. All samples were elongated until failure. Experiments 
were performed in sixtuplicates.
Differential scanning calorimetry (DSC): Analyses using 
differential scanning calorimetry (DSC) were performed using a 
Netzsch DSC 204 F1 Phoenix instrument (Netzsch Geratebau GmbH, 
Selb, Germany). Calibration was done using Adamantan (C10H16), In, 
Sn, Bi, Zn, and CsCl as standards. Approximately 5 mg of the fiber 
samples were transferred into 25 µL aluminum pans, which were 
hermetically sealed and placed in the DSC. Samples were heated from 
-100 to 100°C with 10 K min-1, while monitoring the heat flow. An 
empty pan was used as a reference.
Netzsch Proteus thermal analysis software (Netzsch Geratebau 
GmbH, Selb, Germany) was used to analyze the obtained thermograms. 
The onset and midpoint temperature (Tonset and Tpeak in°C) were 
determined. This was done by determining the temperature at the 
intersection of the baseline of the thermogram and upward slope of the 
peak and temperature at the peak maximum, respectively. The enthalpy 
of the thermal event (∆ H in J g-1, where the weight represents the 
fresh weight of the tissue sample) was determined from the baseline-
corrected area under the peak.
Porosity measurements: The porosity of the specimen types 
that were used in the drug release studies was evaluated by the liquid 
displacement method [24,25]. A cylinder containing a predetermined 
volume of ethanol (V1) was used to immerse the scaffolds. The 
specimens were kept in ethanol for 15 min to allow it to penetrate and 
fill the scaffolds’ pores. The total volume of ethanol with the immersed 
scaffold was determined (V2). After this, the scaffolds were removed 
from the cylinder in order to determine the residual volume of ethanol 
(V3). Equation 1 (Eq. 1) was used to calculate the porosity (%):
P% = (V1-V3) / (V2-V3) - (Eq. 1)
In vitro drug release: Samples that were punched out from both 
coaxially spun and blend electrospun scaffolds were weighed, immersed 
in 20 ml of PBS and kept in an incubator at 37°C. At predetermined time 
points, small aliquots of solution were taken for measuring the light 
absorbance in a UV-Vis spectrometer and added back to the solution. 
Using a UV-Vis spectrometer (LIBRA S22, Biochrom, Germany), the 
concentrations of both ASA and salicylic acid (SA) in the solution 
was determined by measuring the absorbance at 267 and 296 nm, 
respectively. The SA amount in the solution had to be determined 
because ASA is hydrolyzed into SA and acetic acid in PBS [26]. Standard 
calibration plots of concentration versus absorbance were created to 
determine the ASA and SA concentrations in the samples. The amount 
of ASA released in the solution was calculated according to (Eq. 2) [22].
ASAsolution = [SA]solution x Vsolution x MWASA/MWSA  - (Eq. 2) 
Where Vsolution   stands for the volume of the measured solution and 
MWx for the molecular weight of ASA and SA respectively.
In order to calculate the percentage of the released drug over 
time, the ratio between the cumulative amount of ASA released in the 
solution and the amount of ASA that was initially loaded into the fibers 
was calculated according to (Eq. 3):
ASA% = ASAsolution/ASAsample x 100 - (Eq. 3)
The initial amount of ASA in the fibers was calculated by cutting 
samples that were afterwards weighed and immersed in TFE. The 
samples were immediately dissolved and the concentration of ASA 
was measured as described above. All experiments were carried out in 
triplicates.
Statistical analysis
All data are expressed as mean ± standard deviation unless 
otherwise noted. One-way analysis of variance (ANOVA) with post 
hoc Tukey means comparison tests were conducted and p values < 0.05 
were considered significant. 
Results and Discussion 
Morphology and structure of fibers
Three different parameters during polymer solution preparation 
and electrospinning were examined for their effect on the structural, 
physical and mechanical properties of the generated fibers. In 
Figure.1A, SEM pictures depict the differences between the electrospun 
fibers for different solution flow rate, applied voltage and PCL 
concentration. In all cases smooth, cylindrical, bead-less fibers were 
created that formed dense fiber networks. In the first column of Figure 
1A, fibers with different flow rate are depicted. In addition, in the 
middle and right column of the same Figure, electrospun fibers with 
different applied voltage and different PCL concentration are shown, 
respectively. Depended on the operational parameters the fibers 
average diameter and alignment was influenced, as it can be seen from 
Figure 1A. However, due to the fact that the parameter that was kept 
constant each time for each different set of samples was not the same 
between specimens created for each parameter study, a cumulative 
comparison of all of them was not possible in the current study. 
Instead, each parameter was individually assessed. In Figure.1B the 
alignment of the electrospun fibers on the surface of the collector was 
depicted. In case of different flow rates, the standard deviation of the 
fiber alignment values raised from 5.98o (1 ml/h) to 14.36o 5 ml/h). This 
could indicate that increasing flow rates result in less aligned fibers. 
Similarly, increasing applied voltage values led to an increase in the 
standard deviation of fiber alignment, from 6.12o (17 kV) to 10.33o (25 
kV). The fiber alignment also dropped when higher concentration of 
PCL were used (SD = 4.89, PCL concentration = 120 mg/ml compared 
to SD = 20.99, PCL concentration = 200 mg/ml). The data summarized 
in Table 1 show that the average fiber diameter increased with an 
increase in the solution flow rate and PCL concentration from 1.80 ± 
0.47 μm (1 ml/h) to 2.33 ± 0.45 μm (3 ml/h) and from 1.01 ± 0.33 μm 
(120 mg/ml) to 3.37 ± 0.39 μm (200 mg/ml), respectively. The data sets 
are in agreement with previous studies [27,28] resembling the effects 
that have been investigated in conventional blend electrospinning. 
The higher flow rate resulted in the presence of higher amounts of the 
polymeric fluid in the jet, which increased the average fiber diameter. 
Moreover, increased polymer concentration and thus solution viscosity 
resulted in larger average fiber diameters because the elongation of the 
jet required more time and effort. On the other hand, applied voltage 
initially led to an increase in average fiber diameter until 21 kV from 
1.96 ± 0.77 μm (17 kV) to 2.25 ± 0.51 μm (21 kV). For higher voltage 
values the fiber diameter did not increase further and the differences 
in the average values were statistically insignificant (p>0.05). In several 
studies it was concluded that a higher applied voltage leads to increased 
ejection of polymer fluid in a jet but there have been also reports of 
initial decrease in fiber diameter [29-31]. During electrospinning, the 
spinning distance was kept constant at 25 cm. Therefore the electrical 
field generated was mainly affected by the applied voltage. It could be 
possible that changing the spinning distance would result in different 
electrical field which in turn would have influenced the properties of 
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the fibers.
The electrical conductivity of the polymer solutions is depicted in 
Table 1. Increased PCL concentration led to a decrease in electrical 
conductivity of the solutions from 0.85 ± 0.04 μS/cm (120 mg/ml) to 
0.40 ± 0.01 μS/cm (200 mg/ml). The electrical conductivity values of the 
samples that were electrospun under different applied voltage and flow 
rate remained the same as expected since they all came from the same 
solution. From the data in the table it can be concluded that a decrease 
in electrical conductivity leads to an increase in average fiber diameter 
which has been previously reported in other studies [5,12,27,32].
Water contact angle
Static contact angle measurements were conducted in order to study 
the surface differences between the different mats with all experiments 
performed under the same conditions (Figure 2). Results showed that 
an increase in each of the three parameters led to an increase in the 
angle of the water drop in the surface of the fibers. The static contact 
angle in all cases did not exceed 90o and the surfaces can be considered 
as relatively hydrophilic. The statistical analysis showed significant 
difference in the values of the contact angle between flow rates of 1 
and 5 ml/h. More specifically, fibers created with 1, 3 and 5 ml/h flow 
rate exhibited an average static contact angle of 77.66 ± 2.04o, 82.18 ± 
3.34o and 84.58 ± 2.60o, respectively. Moreover, samples created with 
applied voltage of 17 kV (64.90 ± 3.55o) significantly differed from 
samples created with applied voltage of 23 (74.18 ± 1.73o) and 25 kV 
(78.84 ± 4.96o), respectively. Finally, statistically significant differences 
were detected when PCL concentration variance was more than 20 mg/
ml. More specifically, sample 120 mg/ml (69.58 ± 2.44o) statistically 
differed from samples 160 mg/ml, 180 mg/ml and 200 mg/ml (p<0.05). 
Additionally sample 140 mg/ml (71.04 ± 2.10o) statistically differed 
from samples 180 mg/ml and 200 mg/ml (p < 0.05). Finally, samples 
160 mg/ml (74.78 ± 2.56o) and 200 mg/ml (81.90 ± 1.90o) were also 
statistically different (p < 0.05).
The ability to control the surface’s reaction with liquid media is very 
important for drug delivery applications. A surface that would enable 
quick water uptake and infiltration to the inner parts would result in a 
faster release of the pharmaceuticals through the matrix due to diffusion. 
On top of that, this could result in a burst release of the pharmaceuticals 
during the first hours, which is undesirable for sustained drug release 
applications. The nature of the encapsulated pharmaceuticals also plays 
a crucial role in the release kinetics. Water-soluble and water- insoluble 
pharmaceuticals display different release kinetics. On the other hand, a 
less hydrophilic surface could result in an initial delay of diffusion of the 
molecules via the polymeric matrix. Therefore, it was important for this 
study to investigate a way to manipulate the release behavior through 
changes in the structural and physical properties of the fibers, induced 
by parameter optimization.
Figure. 1. SEM images of electrospun fiber mats at different set of parameters; flow rate (first column), applied voltage (second column), PCL concentration (third 
column); magnification = 500x, scale bars = 20 μm (A). Fiber alignment box charts for the different set of parameters (B); n = 50, mean ± SD.
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DSC experiments
The thermograms of bulk PCL pellets and electrospun fibers of 160 
mg/ml PCL are depicted in Figure 3. PCL is a semi-crystalline polymer 
with melting temperature (Tm) of around 60oC and glass transition 
temperature (Tg) at around – 60oC [33]. Both bulk PCL and electrospun 
Sample
Fiber
diameter
Electrical
conductivity
Ultimate tensile strength 
(UTS)
Tensile strain
at Fmax
Young’s modulus Toughness
mean ± SD μm mean ± SD μS/cm mean ± SDMPa mean ± SD mm/mm mean ± SD MPa mean ± SD MJ/m
3
1 ml/h 1.80 ± 0.47 0.52 ± 0.01 4.30 ± 0.61 3.70 ± 0.49 27.93 ± 2.95 15.02 ± 1.98
3 ml/h 2.08 ± 0.40 0.52 ± 0.01 10.09 ± 1.40 0.86 ± 0.02 42.62 ± 3.79 12.87 ± 2.47
5 ml/h 2.33 ± 0.45 0.52 ± 0.01 12.96 ± 1.93 0.66 ± 0.02 47.01 ± 4.19 10.35 ± 1.73
17 kV 1.96 ± 0.77 0.52 ± 0.01 13.64 ± 1.73 0.89 ± 0.05 55.73 ± 3.50 21.53 ± 1.26
19 kV 2.15 ± 0.61 0.52 ± 0.01 9.63 ± 1.05 0.88 ± 0.06 50.81 ± 4.08 19.12 ± 1.09
21 kV 2.25 ± 0.51 0.52 ± 0.01 7.80 ± 2.26 0.82 ± 0.03 38.87 ± 5.22 16.72 ± 0.98
23 kV 2.26 ± 0.41 0.52 ± 0.01 6.99 ± 0.89 0.75 ± 0.03 36.07 ± 5.27 14.50 ± 1.43
25 kV 2.22 ± 0.55 0.52 ± 0.01 5.98 ± 0.59 0.74 ± 0.04 30.29 ± 2.43 12.40 ± 1.33
120 mg/ml 1.01 ± 0.33 0.85 ± 0.04 9.33 ± 1.30 0.62 ± 0.07 35.30 ± 5.22 7.55 ± 1.34
140 mg/ml 1.36 ± 0.40 0.66 ± 0.03 7.72 ± 2.39 0.67 ± 0.06 32.55 ± 6.11 10.57 ± 1.20
160 mg/ml 2.03 ± 0.41 0.48 ± 0.02 5.80 ± 1.04 5.35 ± 0.32 28.11 ± 6.18 13.90 ± 2.10
180 mg/ml 2.44 ± 0.36 0.41 ± 0.01 4.78 ± 0.80 5.81 ± 0.28 22.77 ± 5.30 19.24 ± 1.40
200 mg/ml 3.37 ± 0.39 0.40 ± 0.01 4.10 ± 1.94 6.25 ± 0.30 19.94 ± 3.01 25.79 ± 1.82
Table 1: Summary of structural (average fiber diameter), physical (electrical conductivity), and mechanical properties (ultimate tensile strength, tensile strain at maximum 
force, Young’s modulus and Toughness) of the electrospun fibers.
Figure. 2. Influence of the flow rate (A), applied voltage (B) and PCL con-
centration (C) on the water static contact angle formed on the surface of the 
samples; n = 5, mean ± SD.
Figure. 3. DSC thermograms of a 160 mg/ml PCL scaffold (black dashed 
line) and bulk PCL (black solid line) from -100 oC up to 200 oC. The melt-
ing points Tm (62.8 oC for PCL bulk, 61.3 oC for the PCL scaffold) as well 
as the glass transition points Tg (-61.2 oC for both) can be identified for 
both the bulk material and the scaffold.
fibers had a Tg of -61.2oC. Additionally, the Tm decreased from 62.8oC 
for the pellets to 61.3°C for the electrospun fibers (PCL concentration: 
160 mg/ml). The latter could be attributed to decreased crystallinity of 
the PCL fibers, occurred during the electrospinning process [33,34]. 
Moreover, the bulk PCL that was used was not 100% purified and there 
might have been also some impurities introduced in the fibers from 
the parts of the electrospinning set-up during the process. In fact, in 
the bulk thermogram there was a small peak visible at around 20°C 
and glass transitions at 0oC were visible for both thermograms of PCL 
fibers and bulk PCL. The data from DSC showed that the electrospun 
scaffolds do not display significant chemical changes during the process 
and their properties remain similar to bulk PCL.
Mechanical characterization
Table1 summarizes all mechanical testing data. Increasing values of 
solution flow rate led to increased values of UTS (from 4.3 ± 0.61 MPa 
for 1 ml/h to 12. 96 ± 1.93 MPa for 5 ml/h) (Figure 4A). On the other 
hand, increasing values of applied voltage generated fibers with lower 
average UTS (Figure 4B). The values decreased significantly (p<0.05) 
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until 21 kV (from 13.64 ± 1.73 MPa for 17 kV down to 7.8 ± 2.26 MPa 
for 21 kV) and then further decreased but with a lower rate until 25 
kV (from 7.8 ± 2.26 MPa down to 5.98 ± 0.59 MPa). For the samples 
with different PCL concentrations the ultimate tensile strength values 
decreased from 9.33 ± 1.30 MPa for the 120 mg/ml samples down to 4.1 
± 1.94 MPa for the 200 mg/ml samples (Figure 4C). It can be concluded 
that the average diameter and the alignment of the fibers have a 
different impact on the average UTS values. In case of different flow 
rates, the UTS values coincides with the increase in the average fiber 
diameter, whereas in case of the applied voltage and the concentration 
of PCL, the average UTS dropped when the deviation of the alignment 
of the fibers was higher, in agreement with the data that were presented 
in chapter 3.1.
Tensile strain values at maximum load were within the range of 0.62 
– 0.89 mm/mm for all samples with the exception of 1 ml/h flow rate 
sample and the ones with more than 160 mg/ml PCL concentration. In 
the first case, tensile strain remarkably exceeded 3.7 ± 0.49 mm/mm. 
It is possible that the slow rate of polymer solution deposition on the 
collector resulted in a more favorable macroscopic structure with fibers 
that can be elongated more than 3.5 times their length until failure. This 
can be a very interesting feature for applications that require scaffolds 
with high elongation capacities. In the case of fibers produced with 
more than 160 mg/ml PCL concentration, the tensile strain reached the 
remarkable value of 6.25 ± 0.30 mm/mm for the 200 mg/ml samples. 
Similar behavior has been identified for PCL single jet fibers with 
gradient PCL concentration [35].
Young’s modulus values calculated from the linear slope of the 
stress-strain curves exhibited similar trends with UTS. In the case of 
increasing values of applied voltage and PCL concentration where 
increased deviation in the fiber alignment was observed (Figure 1B), 
the average Young’s modulus values decreased (Figure 4B & C). More 
specifically, Young’s modulus values dropped from 55.73 ± 3.5 MPa for 
the 17 kV samples down to 30.29 ± 2.43 MPa for the 25 kV samples, 
and from 35.3 ± 5.22 MPa down to 19.94 ± 3.01 MPa for the 120 mg/
ml and 200 mg/ml samples, respectively. On the other hand, increasing 
flow rate led to increased Young’s modulus and increased fiber diameter 
values (Figure 4A). Statistical analysis showed that Young’s modulus 
values of the different flow rate samples were statistically different (p 
< 0.05). Additionally, only samples that were generated with a more 
than 2 kV voltage difference were found statistically different (p < 
0.05). Moreover, PCL concentration of 160 mg/ml was found to be 
important since significant differences in Young’s modulus values were 
only found between the samples with concentrations below and above 
that limit. Other groups have also studied how parameters such as 
polymer concentration can influence fiber diameter and alignment and 
eventually the mechanical properties [36]. However, fiber alignment 
is a parameter that needs to be carefully addressed, both qualitatively 
and quantitatively in order to precisely determine the influence 
of the scaffolds’ micro-architecture on the mechanical properties. 
Additionally, the micro-architecture of an electrospun scaffold that 
would be used as a carrier for pharmaceuticals could influence their 
release. Hence, it was crucial to determine if the architecture can be 
controlled sufficiently through parameter optimization. A comparison 
with values from the literature is difficult because of the nature of the 
Figure. 4. Mechanical properties of electrospun PCL scaffolds at different 
parameter set-ups. Young’s modulus and tensile stress at maximum load 
comparative graphs for different flow rate (A), different applied voltage (B) 
and different PCL concentration (C); n = 6, mean ± SD.
Figure. 5. The cumulative release of the drug from the electrospun fibers was 
plotted as a function of time. The error bars represent the standard deviation 
values from the tests. Cumulative ASA release from fibers created with coaxial 
and conventional electrospinning during the first 90 days(A) and the first 8 
Hours (B) respectively; n=3, mean ± SD.
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testing processes and the different protocols that can be followed. 
Furthermore, toughness is another important mechanical property 
for the fabricated materials opted for biomedical applications [37,38]. 
The obtained values are summarized in Table 1. The average toughness 
slightly reduced from 15.02 ± 1.98 MJ/m3 (1 ml/h) to 10.35 ± 1.73 MJ/
m3 (5 ml/h) (p>0.05) and from 21.53 ± 1.26 MJ/m3 (17 kV) to 12.40 
± 1.33 MJ/m3 (25 kV) (p < 0.05). On the other hand, the average 
toughness of the samples created with different PCL concentration 
significantly increased from 7.55 ± 1.34 MJ/m3 (120 mg/ml) to 25.79 ± 
1.82 MJ/m3 (200 mg/ml) (p < 0.05), being comparable with values from 
previous studies, performed with similar materials [37,38].
In vitro drug release study
The cumulative release profiles of ASA incorporated in the 
fabricated fibers using   both electrospinning methods are shown in 
Figure 5. The cumulative amounts of ASA were calculated as the 
release fraction of the total ASA content entrapped within the fibers 
in PBS medium (pH 7.4). The study was carried out in an incubator at 
37 oC over a period of 90 days. Before discussing the obtained results, 
an investigation over the structural and morphological parameters 
of the scaffolds, such as the average porosity and pore size as well as 
the average fiber diameter, had to be performed in order to compare 
appropriately the two electrospinning variants. The average pore size 
for the blend and coaxially electrospun fibers was 7.04± 3.71 μm and 
6.80± 2.70 μm, respectively (p>0.05). Moreover, the average porosity 
values for the blend and coaxial scaffolds were 84.72± 2.76 % and 
86.35± 1.46%, respectively (p>0.05). In addition, the use of the coaxial 
method led to a decrease in the average fiber diameter from 0.85± 0.35 
μm for the blend fibers to 0.80± 0.30 μm, which was not significant 
(p>0.05). Taken together, the morphological and structural analysis of 
both electrospun fibrous scaffolds did not reveal any significant changes 
in the fibers’ characteristics and therefore a direct comparison between 
the drug’s release kinetics from both formulations was possible.
There are two major mechanisms that can determine the release 
of drugs from biodegradable polymeric formulations. The first 
mechanism is driven by polymer degradation and the second through 
small molecule diffusion [39]. According to Woodruff et al., there is no 
evidence reported for significant PCL degradation in such a period of 
time [11]. Thus, it was expected that diffusion through the polymeric 
matrix would be the predominant mechanism for ASA release [40]. 
After 90 days inside the surrounding medium, almost 98% of the 
total amount of ASA was released from the fibers created by blend 
electrospinning and 97% of the fibers created by coaxial electrospinning 
(Figure 5A). Furthermore, in both cases, a biphasic release profile can 
be observed. During the first stage ASA molecules that are present on 
the surface or near it, quickly diffuse to the release medium. The use of 
the coaxial method was considered to ensure that the vast amount of 
ASA would be encapsulated inside the core. Nevertheless, because the 
same polymer and solvent were used in the core and shell solutions, 
a possible mix at the tip of the nozzle during electrospinning might 
have caused a part of ASA to be also present in the shell solution 
and therefore near or at the surface of the fibers. A distinct core-
shell structure was not the case for the fibers created with the coaxial 
approach due to the set-up. Another explanation could be the semi-
crystalline nature of PCL. Kim et al. proposed that the latter was the 
reason of forcing drug aggregates to the surface of the electrospun fibers 
during the electrospinning process [16]. In addition, PCL fiber mats, 
that were created using blend electrospinning, displayed an immediate 
release of ASA that reached almost 60% of the total amount of the 
drug during the initial 8h (Figure 5B). On the other hand, this burst 
effect was lower in the case of the coaxially spun fibers, where ASA 
was expected to be mainly encapsulated in the core of the fibers. In 
this case, the release of ASA almost reached 34% during the initial 8h 
(Figure 5B). In both cases the initial burst release was followed by a 
sustained release period that lasted until the end of the experiment. 
During the second stage of the release profile, the coaxially spun fibers 
resulted in a more gradual release through time. At day 45, which was 
the middle point of the study, the cumulative release of ASA reached 
almost 85% while the amount released from the conventional blend 
electrospun fibers was already more than 97%. During this stage, the 
ASA molecules that were encapsulated deeper inside the fibers had to 
diffuse through longer distances inside the polymeric matrix. In the 
case of coaxially spun fibers, a considerable amount of ASA molecules 
are expected to be distributed mainly near the core and therefore would 
require longer time to diffuse. This could explain the differences in the 
release profiles between the methods and also support the hypothesis 
that coaxially spun fibers are more suitable for sustained release of 
pharmaceuticals over time, even if a clear core-shell structure could 
not be achieved. Moreover, fiber diameter seems to play an important 
role in this matter since it can influence the time the molecules need 
to diffuse through the matrix, making it a crucial property to control 
through the optimization of the aforementioned solution and process 
parameters. Del Gaudio et al. presented similar results for the same time 
periods, with total study duration of one week [22]. In addition, several 
other groups including Zhang et al. and Yan et al. have presented results 
indicating the suitability of electrospun fibers for prolonged release of 
pharmaceuticals [9,20,23]. 
Conclusion
PCL fibrous meshes were created using the coaxial electrospinning 
technique. The main goal of this work was to determine if by controlling 
different parameters before and during electrospinning a prediction or 
adjustability of the final products could be achieved. Results showed 
that different solution and process parameters affect the structural and 
mechanical properties of the fibers in a similar manner as during blend 
electrospinning. Polymer concentration is one of the most important 
parameters. Increased PCL concentration led to thicker, less aligned 
fibers and applied voltage had similar effects. DSC results showed 
that there were only minor visible changes between the electrospun 
scaffolds and PCL in bulk form. In addition, the mechanical studies 
showed that varying structural properties through changes in process 
and solution parameters can greatly affect the tensile stress the fibers 
can withstand when maximum load is applied. Moreover, coaxially 
spun fibers showed a more sustained release profile of ASA compared 
to fibers created by blend electrospinning, leading to the conclusion 
that they would be more suitable as drug delivery carriers, even without 
having a distinct core-shell morphology. Summarizing, the results of 
this study show that PCL electrospun fibers can be methodically and 
easily modified to obtain desired properties through a careful and 
well-designed optimization of the parameters that influence the initial 
preparation of the polymeric solutions as well as the process itself. 
Hence, PCL electrospun fibers are promising candidates as scaffolds for 
sustained drug delivery applications.
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